Metrizamide--CSF contrast medium. Analysis of clinical application in 215 patients
- PMID: 860047
- DOI: 10.1148/123.3.779
Metrizamide--CSF contrast medium. Analysis of clinical application in 215 patients
Abstract
Two-hundred-fifteen patients were evaluated with metrizamide, a new water-soluble contrast agent for use in the subarachnoid spaces. Side effects were reported in 67% of these; 39% were moderate or severe. Cervical injections monitored by fluoroscopy provide the most precise positioning of the medium. The benefits of metrizamide use outweigh its risk.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
